Cary Street Partners Investment Advisory LLC Pds Biotechnology Corp Transaction History

Cary Street Partners Investment Advisory LLC

$152 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 13, 2023	BUY	$4.8 - $6.4 $19,200 - $25,600	4,000 Added 187.71%	6,131 $30,000
Q4 2022 Feb 14, 2023	BUY	$3.28 - $13.2 $6,989 - $28,129	2,131 New	2,131 $28,000

Others Institutions Holding PDSB

# of Institutions

Shares Held

4.22M

Call Options Held

170K

Put Options Held

6.7K

Vanguard Group Inc Valley Forge, PA

1.51M
Shares

$2.02 Million
0.0% of portfolio
Black Rock Inc. New York, NY

487K
Shares

$652,535
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

417K
Shares

$559,070
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

247K
Shares

$330,949
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

220K
Shares

$295,088
0.0% of portfolio

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $38.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account